Riskpilot← Back to searchSign inGet full accessHousemed Oy Ab
OYActiveY-tunnus 2403905-7Lt. 2Other human health activities n.e.c. · NACE 8699Est. 201110 employees
Revenue 2024
EUR 669K
+20% vs 2023
EBITDA margin
23.0%
-7% vs 2023
Equity ratio
81.5%
Financial strength
Net profit 2024
EUR 112K
+6% vs 2023
| Revenue | EUR 669K | +20% |
| EBITDA | EUR 154K | -7% |
| Net profit | EUR 112K | +6% |
| Total assets | EUR 678K | +3% |
| Equity | EUR 552K | +15% |
| Employees | 10 | — |
Legal name
Housemed Oy Ab
Y-tunnus number
2403905-7
Legal form
Osakeyhtiö
NACE code
8699 · Other human health activities n.e.c.
Founded
18. huhtikuuta 2011
Share capital
EUR 2 500
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on ydintoimialoina ovat; hoiva ja terveysalaan liittyvät erilaiset palvelut. Toimialaan kuuluu myös yleistoimiala.
Address
Lt. 2
Phone
+3580407209147
Email
ssalokorpi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 365 | 427 | 514 | 560 | 669 |
| Staff expenses | −152 | −222 | −214 | −258 | −387 |
| EBITDA | 190 | 181 | 225 | 165 | 154 |
| Depreciation & amort. | −2 | −15 | −34 | −28 | −10 |
| EBIT | 189 | 167 | 190 | 137 | 145 |
| Net financials | — | −6 | −6 | −6 | −4 |
| Profit before tax | 189 | 161 | 184 | 132 | 140 |
| Tax | 38 | 32 | 37 | 27 | 28 |
| Net profit | 151 | 128 | 147 | 105 | 112 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 229 | 499 | 616 | 657 | 678 |
| Equity | 166 | 281 | 407 | 479 | 552 |
| Long-term debt | 1 | 106 | 160 | 123 | 47 |
| Short-term debt | 62 | 112 | 49 | 55 | 78 |
| Total debt | 63 | 218 | 209 | 178 | 125 |
EBITDA margin
23.0%
This company
15.8%
Market median
+46% vs market
20202024
Equity ratio
81.5%
This company
38.2%
Market median
+113% vs market
20202024
Return on equity
20.2%
This company
18.4%
Market median
+10% vs market
20202024
Net profit margin
16.7%
This company
8.1%
Market median
+106% vs market
20202024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
0.23×
This company
0.62×
Market median
+63% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
TM Deputy Member | Deputy Member | 2019 |
| Former (2) | ||
RH Deputy Member | Deputy Member | 2011 – 2019 |
AM Chief Executive Officer | Chief Executive Officer | 2011 – 2019 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2011 | |
| Board of Directors | 2019 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Housemed Oy Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rami Hannu Tapio Pohja | Deputy Member | 0 companies |
| Tiia Maria Salokorpi | Deputy Member | 0 companies |
| Anne Maarit Maaninka | Chief Executive Officer | 0 companies |
| Satu Irina Keskitalo | Chairperson | 0 companies |
| Toni Kristian Salokorpi | Board of Directors | 0 companies |